Sorrento Therapeutics Inc (NASDAQ:SRNE)

12.92
Delayed Data
As of Feb 27
 -0.34 / -2.56%
Today’s Change
3.10
Today|||52-Week Range
16.40
+28.30%
Year-to-Date

Stock Price Forecast

The 3 analysts offering 12-month price forecasts for Sorrento Therapeutics Inc have a median target of 25.00, with a high estimate of 30.00 and a low estimate of 13.00. The median estimate represents a +93.50% increase from the last price of 12.92.

Analyst Recommendations

The current consensus among 3 polled investment analysts is to Buy stock in Sorrento Therapeutics Inc. This rating has held steady since February, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.26
Sales
$1.4M
Reporting Date
Jun 03

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -1.28%
 
 
 
 
 
 
Growthannually 27.34%
 
 
 
 

Sales

Growthquarterly 39.33%
 
 
 
 
 
 
Growthannually 34.74%
 
 
 
 
Key to the earnings and sales forecast charts.

To view my watchlist

Not a member yet?

Sign up now for a free account